Health Catalyst (NASDAQ:HCAT) Receives “Equal Weight” Rating from Wells Fargo & Company

Health Catalyst (NASDAQ:HCAT)‘s stock had its “equal weight” rating restated by research analysts at Wells Fargo & Company in a note issued to investors on Wednesday, Marketbeat reports. They currently have a $1.00 price target on the stock, down from their prior price target of $5.00. Wells Fargo & Company‘s price objective suggests a potential downside of 14.53% from the stock’s current price.

HCAT has been the subject of a number of other research reports. Raymond James Financial set a $3.00 price objective on Health Catalyst in a research report on Friday. Stifel Nicolaus reduced their target price on shares of Health Catalyst from $3.75 to $2.00 and set a “hold” rating on the stock in a report on Friday, March 13th. Cantor Fitzgerald decreased their price target on shares of Health Catalyst from $4.00 to $3.00 and set a “neutral” rating on the stock in a research note on Friday. Stephens lowered their price target on shares of Health Catalyst from $3.50 to $2.00 and set an “equal weight” rating for the company in a report on Friday, March 13th. Finally, Canaccord Genuity Group cut their price objective on shares of Health Catalyst from $5.00 to $2.00 and set a “buy” rating for the company in a research report on Friday. Four investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $2.80.

Health Catalyst Price Performance

Shares of NASDAQ:HCAT opened at $1.17 on Wednesday. The business’s fifty day moving average price is $2.01 and its two-hundred day moving average price is $2.52. The stock has a market cap of $86.10 million, a PE ratio of -0.46 and a beta of 1.77. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.89 and a current ratio of 1.89. Health Catalyst has a one year low of $1.16 and a one year high of $5.06.

Health Catalyst (NASDAQ:HCAT) last released its quarterly earnings results on Thursday, March 12th. The company reported $0.08 earnings per share for the quarter, missing the consensus estimate of $0.10 by ($0.02). Health Catalyst had a negative return on equity of 4.30% and a negative net margin of 57.20%.The company had revenue of $74.68 million for the quarter, compared to analysts’ expectations of $73.99 million. On average, analysts forecast that Health Catalyst will post -0.33 EPS for the current fiscal year.

Hedge Funds Weigh In On Health Catalyst

Several large investors have recently added to or reduced their stakes in HCAT. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in Health Catalyst by 7.9% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 36,047 shares of the company’s stock worth $163,000 after buying an additional 2,624 shares during the last quarter. Campbell & CO Investment Adviser LLC lifted its holdings in shares of Health Catalyst by 9.7% during the 2nd quarter. Campbell & CO Investment Adviser LLC now owns 43,051 shares of the company’s stock worth $162,000 after acquiring an additional 3,808 shares during the period. The Manufacturers Life Insurance Company lifted its holdings in shares of Health Catalyst by 19.6% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 26,491 shares of the company’s stock worth $100,000 after acquiring an additional 4,341 shares during the period. BNP Paribas Financial Markets boosted its position in shares of Health Catalyst by 71.7% in the third quarter. BNP Paribas Financial Markets now owns 16,355 shares of the company’s stock worth $47,000 after acquiring an additional 6,832 shares during the last quarter. Finally, Invesco Ltd. grew its holdings in Health Catalyst by 6.5% in the fourth quarter. Invesco Ltd. now owns 118,591 shares of the company’s stock valued at $283,000 after purchasing an additional 7,186 shares during the period. 85.00% of the stock is currently owned by hedge funds and other institutional investors.

Health Catalyst Company Profile

Health Catalyst (NASDAQ: HCAT) is a healthcare data and analytics technology company founded in 2008 and headquartered in Salt Lake City, Utah. The company went public in 2019 and has since focused on delivering a unified data platform that helps healthcare organizations aggregate and analyze clinical, financial and operational information.

The core of Health Catalyst’s offering is the Data Operating System (DOS), a modular data management platform that integrates disparate data sources—from electronic health records to claims and patient-generated data—into a single analytics environment.